Yoshihisa Nakagawa Selected Research

pitavastatin (itavastatin)

10/2022	Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease.
10/2021	Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy.
3/2018	Rationale and Design of Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease (REAL-CAD) Trial.
1/2018	High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
1/2013	Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study.
1/2012	Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study.
12/2011	Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
10/2010	More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.
9/2010	Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study.
6/2010	Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihisa Nakagawa Research Topics

Disease

55	Myocardial Infarction 01/2022 - 01/2009
40	Thrombosis (Thrombus) 01/2022 - 02/2009
38	Hemorrhage 05/2022 - 09/2011
30	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 12/2006
24	Stroke (Strokes) 06/2022 - 06/2009
19	Heart Failure 01/2022 - 05/2007
18	ST Elevation Myocardial Infarction 01/2022 - 10/2010
18	Acute Coronary Syndrome 01/2022 - 12/2006
16	Atrial Fibrillation 05/2022 - 09/2010
10	Death (Near-Death Experience) 01/2021 - 09/2011
8	Diabetes Mellitus 09/2022 - 06/2010
8	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 06/2002
7	Ischemic Stroke 06/2022 - 01/2018
6	Hypertension (High Blood Pressure) 09/2022 - 11/2010
6	Infarction (Infarctions) 01/2018 - 10/2004
5	Left Ventricular Dysfunction 02/2019 - 05/2007
4	Neoplasms (Cancer) 01/2022 - 01/2018
4	Chronic Renal Insufficiency 01/2021 - 10/2013
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2022 - 01/2021
3	Cardiogenic Shock 01/2022 - 11/2004
3	Cardiac Arrhythmias (Arrythmia) 11/2020 - 01/2017
3	Anemia 11/2019 - 10/2013
2	Fabry Disease (Fabry's Disease) 10/2022 - 02/2021
2	Body Weight (Weight, Body) 01/2022 - 02/2021
2	Non-ST Elevated Myocardial Infarction 01/2022 - 01/2021
2	AIDS-Related Complex (ARC) 02/2021 - 11/2019
2	Ventricular Fibrillation 02/2021 - 12/2011
2	Heart Diseases (Heart Disease) 12/2020 - 04/2015
2	Hemorrhagic Stroke 11/2019 - 01/2019
2	Neointima 12/2017 - 01/2014
2	Constrictive Pericarditis 01/2017 - 01/2013
2	Tachycardia (Tachyarrhythmias) 01/2016 - 09/2015
2	Unstable Angina 10/2014 - 01/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2013 - 08/2010
2	Pericarditis 01/2013 - 03/2006
1	Proteinuria 10/2022
1	Albuminuria 09/2022
1	Dyslipidemias (Dyslipidemia) 09/2022
1	Long QT Syndrome 04/2022
1	Infections 01/2022
1	Stable Angina 10/2021
1	Angina Pectoris 08/2021
1	Cardiomyopathies (Cardiomyopathy) 07/2021

Drug/Important Bio-Agent (IBA)

20	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 12/2006
13	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 09/2012
12	pitavastatin (itavastatin)FDA Link 10/2022 - 12/2006
9	LipidsIBA 10/2022 - 07/2009
9	Sirolimus (Rapamycin)FDA Link 01/2018 - 06/2005
8	omega-Chloroacetophenone (Mace)IBA 01/2020 - 04/2010
8	Atorvastatin (Lipitor)FDA Link 01/2013 - 12/2006
7	MetalsIBA 01/2022 - 03/2004
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 02/2009
5	Prasugrel Hydrochloride FDA Link 05/2022 - 01/2020
5	Streptokinase FDA Link 11/2019 - 08/2014
5	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2019 - 08/2014
5	thienopyridineIBA 11/2015 - 02/2009
4	LDL CholesterolIBA 10/2022 - 01/2018
4	HDL CholesterolIBA 01/2022 - 09/2010
4	Clopidogrel (Plavix)FDA Link 01/2022 - 01/2019
4	Hemoglobins (Hemoglobin)IBA 11/2019 - 04/2010
4	BESIBA 12/2017 - 07/2013
3	AnticoagulantsIBA 05/2022 - 07/2014
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 09/2010
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 08/2019
3	APTIBA 01/2019 - 04/2012
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019 - 07/2017
2	alpha-Galactosidase (Beano)IBA 10/2022 - 02/2021
2	C-Reactive ProteinIBA 09/2022 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2020
2	Pharmaceutical PreparationsIBA 07/2021 - 08/2015
2	pro-brain natriuretic peptide (1-76)IBA 12/2020 - 08/2019
2	Warfarin (Coumadin)FDA LinkGeneric 11/2020 - 01/2017
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2018 - 10/2004
2	CreatinineIBA 01/2017 - 10/2014
2	Dihydrotachysterol (AT 10)IBA 11/2016 - 12/2015
2	AdiponectinIBA 09/2010 - 05/2007
1	Febuxostat FDA Link 10/2022
1	Uric Acid (Urate)IBA 10/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	polyglucosanIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	galactomannanIBA 01/2022
1	AntigensIBA 01/2022
1	Anti-Arrhythmia AgentsIBA 10/2021
1	AnthracyclinesIBA 07/2021
1	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2021

Therapy/Procedure

70	Percutaneous Coronary Intervention 06/2022 - 06/2005
52	Stents 06/2022 - 06/2002
51	Therapeutics 10/2022 - 02/2009
17	Drug-Eluting Stents 01/2022 - 02/2009
16	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 09/2008
6	Catheter Ablation 10/2021 - 01/2015
4	Renal Dialysis (Hemodialysis) 01/2018 - 01/2012
3	Operative Surgical Procedures 08/2014 - 04/2012
2	Defibrillators (Defibrillator) 04/2022 - 08/2015
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 04/2022 - 11/2020
2	Blood Transfusion (Blood Transfusions) 01/2021 - 02/2017
2	Secondary Prevention 07/2018 - 02/2017
1	Enzyme Replacement Therapy 10/2022
1	Radiotherapy 07/2021